the dose escalation thing finally clicked for me and I want to write it down
Been lurking in c/sideeffects for about 18 months and finally have something worth posting. Short version: week 46, 12.5mg, and triple agonist is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 23 threads, and the answers split roughly down the middle. What I actually want…
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
the dosing is steep, the the food-noise thing reports are real, and nobody knows the human safety yet
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
That is net peptide content, not purity. Different number, different meaning.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
research use only, handling and analysis, not protocols
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.